[144] Astera Labs, Inc. SEC Filing
Rhea-AI Filing Summary
Astera Labs' Form 144 discloses a proposed sale of 26,000 common shares on NASDAQ through broker Stifel, with an aggregate market value of $4,556,737.00 and the issuer reported 162,150,000 shares outstanding. The filing shows the shares were acquired in private placements: 1,000 on 05/17/2022 and 25,000 on 11/08/2019. A related sale by Stefan A Dyckerhoff of 26,000 shares on 08/07/2025 for $4,508,959.00 is also listed. The notice includes the seller's representation that they do not possess undisclosed material adverse information and contains the standard legal warning about intentional misstatements.
Positive
- None.
Negative
- None.
Insights
TL;DR: Form 144 discloses a proposed sale of 26,000 ALAB common shares via Stifel on NASDAQ.
The filing specifies the intended transaction size (26,000 shares) and the stated aggregate market value ($4,556,737.00), plus the company's outstanding share count (162,150,000). It also documents prior acquisitions by the filer through private placements and a recent sale by Stefan A Dyckerhoff on 08/07/2025. The form contains the seller's certification regarding material nonpublic information, consistent with normal Rule 144 disclosures.
TL;DR: Filing includes required seller representations and a transaction record; it documents acquisition dates and a recent sale.
The notice includes explicit acquisition history (private placements on 11/08/2019 and 05/17/2022), the broker on record (Stifel), and the seller's declaration about undisclosed material information. Those elements align with Rule 144 procedural disclosure requirements and provide a clear audit trail for the reported transactions.